|
SLC38A7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.67639999995684E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.444300E-03 |
| Normal-vs-Stage2 |
5.256800E-03 |
| Normal-vs-Stage3 |
3.5731000003203E-07 |
| Normal-vs-Stage4 |
1.079060E-03 |
| Stage1-vs-Stage2 |
4.241400E-01 |
| Stage1-vs-Stage3 |
2.435700E-02 |
| Stage1-vs-Stage4 |
3.297200E-01 |
| Stage2-vs-Stage3 |
4.715200E-01 |
| Stage2-vs-Stage4 |
9.756800E-01 |
| Stage3-vs-Stage4 |
4.470000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.35949999988416E-07 |
| Normal-vs-AfricanAmerican |
2.773800E-01 |
| Normal-vs-Asian |
3.739800E-01 |
| Caucasian-vs-AfricanAmerican |
3.735400E-01 |
| Caucasian-vs-Asian |
8.760300E-03 |
| AfricanAmerican-vs-Asian |
2.553600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15010000026439E-07 |
| Normal-vs-Female |
1.055640E-02 |
| Male-vs-Female |
5.263900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.253800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.756490E-03 |
| Normal-vs-Age(61-80Yrs) |
2.46530000003187E-06 |
| Normal-vs-Age(81-100Yrs) |
2.2685999999994E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.642600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.610000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.964600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.779500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.219800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.096800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.093200E-01 |
| Normal-vs-Grade 2 |
8.57359999995033E-07 |
| Normal-vs-Grade 3 |
2.762900E-04 |
| Normal-vs-Grade 4 |
5.361100E-03 |
| Grade 1-vs-Grade 2 |
2.458200E-01 |
| Grade 1-vs-Grade 3 |
2.533600E-01 |
| Grade 1-vs-Grade 4 |
2.637400E-01 |
| Grade 2-vs-Grade 3 |
3.884800E-01 |
| Grade 2-vs-Grade 4 |
4.813000E-01 |
| Grade 3-vs-Grade 4 |
9.754200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.06859995799391E-09 |
| Normal-vs-ccB subtype |
2.610600E-01 |
| ccA subtype-vs-ccB subtype |
4.18270000002163E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.979500E-04 |
| Normal-vs-N1 |
7.588400E-01 |
| N0-vs-N1 |
4.239200E-01 |
|
|
